Source:http://linkedlifedata.com/resource/pubmed/id/10629384
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
4
|
| pubmed:dateCreated |
2000-3-30
|
| pubmed:abstractText |
The substance Mifegyne, an antigestagen, can profoundly influence progesterone-dependent situations given the relevant indications and preconditions.
|
| pubmed:language |
ger
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
1018-8843
|
| pubmed:author | |
| pubmed:copyrightInfo |
Copyright 1999 S. Karger AG, Basel
|
| pubmed:issnType |
Print
|
| pubmed:volume |
39
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
207
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading | |
| pubmed:year |
1999
|
| pubmed:articleTitle |
[Mifegyne (RU-486)].
|
| pubmed:affiliation |
Klinische Abteilung für Gynäkologische Endokrinologie und Sterilitätsbehandlung, Universitäts-Klinik für Frauenheilkunde, Wien, Osterreich.
|
| pubmed:publicationType |
Journal Article,
English Abstract
|